These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 33410258)
1. Risk assessment and genetic counseling for hereditary breast and ovarian cancer syndromes-Practice resource of the National Society of Genetic Counselors. Berliner JL; Cummings SA; Boldt Burnett B; Ricker CN J Genet Couns; 2021 Apr; 30(2):342-360. PubMed ID: 33410258 [TBL] [Abstract][Full Text] [Related]
2. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: recommendations of the National Society of Genetic Counselors. Berliner JL; Fay AM; J Genet Couns; 2007 Jun; 16(3):241-60. PubMed ID: 17508274 [TBL] [Abstract][Full Text] [Related]
3. A survey of genetic counselors about the needs of 18-25 year olds from families with hereditary breast and ovarian cancer syndrome. Werner-Lin A; Ratner R; Hoskins LM; Lieber C J Genet Couns; 2015 Feb; 24(1):78-87. PubMed ID: 25011978 [TBL] [Abstract][Full Text] [Related]
4. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center. Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535 [TBL] [Abstract][Full Text] [Related]
5. Genetic counselors' perspectives on population-based screening for BRCA-related hereditary breast and ovarian cancer and Lynch syndrome. De Simone LM; Arjunan A; Vogel Postula KJ; Maga T; Bucheit LA J Genet Couns; 2021 Feb; 30(1):158-169. PubMed ID: 32562467 [TBL] [Abstract][Full Text] [Related]
6. [Genetic Counseling of HBOC and Japanese Organization of HBOC]. Fukushima Y Gan To Kagaku Ryoho; 2017 Feb; 44(2):107-110. PubMed ID: 28223668 [TBL] [Abstract][Full Text] [Related]
7. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian. Hessock M; Brewer T; Hutson S; Anderson J Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425 [TBL] [Abstract][Full Text] [Related]
8. Prenatal genetic counseling practices regarding recommendations for cancer genetic counseling: A retrospective chart review from two academic institutions. Saba LF; Sullivan CM; Solomon T; Huguenard S; Nassef SA J Genet Couns; 2022 Oct; 31(5):1062-1070. PubMed ID: 35434961 [TBL] [Abstract][Full Text] [Related]
9. NSGC practice guideline: risk assessment and genetic counseling for hereditary breast and ovarian cancer. Berliner JL; Fay AM; Cummings SA; Burnett B; Tillmanns T J Genet Couns; 2013 Apr; 22(2):155-63. PubMed ID: 23188549 [TBL] [Abstract][Full Text] [Related]
10. Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer. Szender JB; Kaur J; Clayback K; Hutton ML; Mikkelson J; Odunsi K; Dresbold C Int J Gynecol Cancer; 2018 Jan; 28(1):26-33. PubMed ID: 28930807 [TBL] [Abstract][Full Text] [Related]
11. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care. Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215 [TBL] [Abstract][Full Text] [Related]
12. Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs. Bellcross CA Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766 [TBL] [Abstract][Full Text] [Related]
13. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system. Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH Clin Genet; 2022 Mar; 101(3):324-334. PubMed ID: 34927729 [TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171 [TBL] [Abstract][Full Text] [Related]
15. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727 [TBL] [Abstract][Full Text] [Related]
16. Investigating barriers to genetic counseling and germline mutation testing in women with suspected hereditary breast and ovarian cancer syndrome and Lynch syndrome. Shaw J; Bulsara C; Cohen PA; Gryta M; Nichols CB; Schofield L; O'Sullivan S; Pachter N; Hardcastle SJ Patient Educ Couns; 2018 May; 101(5):938-944. PubMed ID: 29273311 [TBL] [Abstract][Full Text] [Related]
17. Cancer Genetic Counseling and Testing in an Era of Rapid Change. Hooker GW; Clemens KR; Quillin J; Vogel Postula KJ; Summerour P; Nagy R; Buchanan AH J Genet Couns; 2017 Dec; 26(6):1244-1253. PubMed ID: 28434142 [TBL] [Abstract][Full Text] [Related]
18. Genetic Counseling, Testing, and Management of HBOC in India: An Expert Consensus Document from Indian Society of Medical and Pediatric Oncology. Malhotra H; Kowtal P; Mehra N; Pramank R; Sarin R; Rajkumar T; Gupta S; Bapna A; Bhattacharyya GS; Gupta S; Maheshwari A; Mannan AU; Reddy Kundur R; Sekhon R; Singhal M; Smruti BK; Sp S; Suryavanshi M; Verma A JCO Glob Oncol; 2020 Jul; 6():991-1008. PubMed ID: 32628584 [TBL] [Abstract][Full Text] [Related]
19. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines. Kotnik U; Peterlin B; Lovrecic L BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720 [TBL] [Abstract][Full Text] [Related]
20. Hereditary breast-ovarian cancer: clinical findings and medical management. Marshall M; Solomon S Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]